Ascentage Pharma Group International (AAPG) Payables (2023 - 2025)
Historic Payables for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $16.4 million.
- Ascentage Pharma Group International's Payables changed N/A to $16.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $16.4 million, marking a year-over-year change of. This contributed to the annual value of $12.8 million for FY2024, which is 2489.45% up from last year.
- As of Q2 2025, Ascentage Pharma Group International's Payables stood at $16.4 million.
- Over the past 5 years, Ascentage Pharma Group International's Payables peaked at $16.4 million during Q2 2025, and registered a low of $10.1 million during Q4 2023.
- In the last 3 years, Ascentage Pharma Group International's Payables had a median value of $12.8 million in 2024 and averaged $13.1 million.
- Examining YoY changes over the last 5 years, Ascentage Pharma Group International's Payables showed a top increase of 2724.6% in 2024 and a maximum decrease of 2724.6% in 2024.
- Quarter analysis of 3 years shows Ascentage Pharma Group International's Payables stood at $10.1 million in 2023, then grew by 27.25% to $12.8 million in 2024, then rose by 28.15% to $16.4 million in 2025.
- Its Payables stands at $16.4 million for Q2 2025, versus $12.8 million for Q4 2024 and $10.1 million for Q4 2023.